SB 461: Generally revise administration of drug and substance laws - Montana

SB0461_2(14).pdf → SB0461_3.pdf · 5 edits

MODERATE

The bill was significantly rewritten to shift its primary focus from regulating hemp and intoxicating beverages to specifically addressing kratom products. The new version establishes a 'Kratom Consumer Protection Act' that defines kratom and its extracts, while simultaneously creating an exemption for businesses that serve fresh, non-synthesized kratom to the public. This change matters because it alters the legal landscape for kratom vendors, potentially allowing them to operate without state regulation if they adhere to specific freshness and synthesis standards, whereas the previous version focused on broad prohibitions against unregulated intoxicating products.

Scope change

The bill's scope changed from a general prohibition on unregulated intoxicating products and hemp regulation to a specific framework governing kratom, including new definitions for kratom types and exemptions for entities providing fresh kratom products.

DEFINITION

Added specific definitions for 'Kratom', 'Kratom extract', 'Kratom processor', and 'Synthesized material' to clarify what substances are covered.

EXEMPTIONS

Added an exemption allowing entities to provide fresh and non-synthesized kratom products to the public without prohibition by state or local governments.

SCOPE

Removed the broad prohibition on consuming unregulated intoxicating beverages and products, replacing it with kratom-specific regulations.

REQUIREMENT

Modified the regulatory approach to focus on prohibiting the sale of synthesized or adulterated kratom products while permitting fresh forms under specific conditions.

TIMELINE

Added a codification instruction directing the new kratom sections to be added to Title 30, Chapter 14 of the Montana Code Annotated.

SB0461_2(3).pdf → SB0461_2(4).pdf · 7 edits

MODERATE

This bill updates the definitions in the state's marijuana code to modernize terminology and clarify legal standards. It replaces the outdated 'medical marijuana' framework with a unified 'adult-use' system, expands the list of qualifying medical conditions, and introduces specific definitions for beneficial ownership and affiliates to ensure regulatory compliance.

Scope change

The bill shifts the regulatory scope from a dual medical and adult-use system to a primary focus on adult-use, while retaining and clarifying medical provisions. It broadens eligibility by adding new medical conditions and redefines key terms to align with federal securities standards.

DEFINITION

Renamed the primary dispensary definition from 'medical marijuana dispensary' to 'adult-use dispensary' to reflect the new legal framework.

Added a new definition for 'Affiliate' to clarify relationships between business owners and managers for regulatory oversight.

Introduced 'Controlling beneficial owner' to establish specific thresholds (5% and 15%) for identifying individuals with significant influence over marijuana businesses.

Added a definition for 'Canopy' to precisely measure the square footage of live plant production areas for licensing limits.

Updated the 'Department' definition to remove incomplete text and streamline the reference to the Department of Revenue.

Added a new definition for 'Financial interest' to explicitly exclude bank interests while including private loans and convertible securities.

ELIGIBILITY

Expanded the list of 'Debilitating medical conditions' to include posttraumatic stress disorder and updated the description of chronic pain criteria.

SB0461_1(3).pdf → SB0461_2.pdf · 3 edits

MINOR

The bill text was reformatted to correct numbering errors and add missing punctuation for clarity. The substantive definitions and scope of the hemp regulation bill remain unchanged, though a minor formatting error in the definition of 'Debilitating medical condition' was fixed by renumbering the list items.

TECHNICAL

Fixed a numbering error in the definition of 'Debilitating medical condition' where items were misaligned between the old and new versions.

Added missing semicolons and periods to the summary description and section titles for better readability.

Corrected the header formatting to align the legislature year and bill number properly.

LC4318.pdf → SB0461_1.pdf · 1 edit

MINOR

The bill was renamed from LC 4318 to SB 461, indicating a transition from a committee or legislative council draft to a formal Senate Bill introduced by Senator Novak. The document structure was updated to reflect this official Senate status, including changes to the header and page footers. No substantive policy changes, such as new definitions, funding amounts, or eligibility criteria, were identified in the provided text.

TECHNICAL

The bill identifier was changed from LC 4318 to SB 461, and the sponsor was added as S. Novak, reflecting the bill's progression in the legislative process.

Generally revise administration of drug and substance laws

What changed between versions

How they voted

Actions timeline

Sponsors